Skip to main content

Table 1 Metabolic risk profiles and characteristics of analysis population at the most recent examination point

From: Media use trajectories and risk of metabolic syndrome in European children and adolescents: the IDEFICS/I.Family cohort

 

Most recent examination point

All

W2

W3

 

Sex

Boys

Girls

Boys

Girls

N (%)

N (%)

N (%)

N (%)

N (%)

All

2550 (24.6)

2543 (24.5)

2594 (25.0)

2672 (25.8)

10,359 (100.0)

DM trajectory

 Below mean

1274 (12.3)

1249 (12.1)

1312 (12.7)

1546 (14.9)

5381 (51.9)

 Above mean

1276 (12.3)

1294 (12.5)

1282 (12.4)

1126 (10.9)

4978 (48.1)

Age group

  < 12 years

2550 (24.6)

2543 (24.5)

1410 (13.6)

1428 (13.8)

7931 (76.6)

  ≥ 12 years

0 (0)

0 (0)

1184 (11.4)

1244 (12.0)

2428 (23.4)

ISCEDa

 Low

143 (1.4)

121 (1.2)

147 (1.4)

139 (1.3)

550 (5.3)

 Medium

1088 (10.5)

1089 (10.5)

1104 (10.7)

1160 (11.2)

4441 (42.9)

 High

1297 (12.5)

1309 (12.6)

1323 (12.8)

1353 (13.1)

5282 (51.0)

 Missing

22 (0.2)

24 (0.2)

20 (0.2)

20 (0.2)

86 (0.8)

HDAS

 High

1336 (12.9)

1395 (13.5)

1085 (10.5)

1114 (10.8)

4930 (47.6)

 Low

1097 (10.6)

1013 (9.8)

1426 (13.8)

1469 (14.2)

5005 (48.3)

 Missing

117 (1.1)

135 (1.3)

83 (0.8)

89 (0.9)

424 (4.1)

Snack intake

 High

1012 (9.8)

967 (9.3)

1643 (15.9)

1610 (15.5)

5232 (50.5)

 Low

1263 (12.2)

1261 (12.2)

723 (7.0)

858 (8.3)

4105 (39.6)

 Missing

275 (2.7)

315 (3.0)

228 (2.2)

204 (2.0)

1022 (9.9)

Puberty status

 Pre-pubertal

1123 (10.8)

999 (9.6)

1387 (13.4)

1514 (14.6)

5023 (48.5)

 Pubertal

0 (0.0)

0 (0.0)

1040 (10.0)

1035 (10.0)

2075 (20.0)

 Missing

1427 (13.8)

1544 (14.9)

167 (1.6)

123 (1.2)

3261 (31.5)

Country

 Italy

326 (3.1)

297 (2.9)

530 (5.1)

514 (5.0)

1667 (16.1)

 Estonia

269 (2.6)

301 (2.9)

403 (3.9)

444 (4.3)

1417 (13.7)

 Cyprus

327 (3.2)

333 (3.2)

524 (5.1)

509 (4.9)

1693 (16.3)

 Belgium

311 (3.0)

303 (2.9)

103 (1.0)

126 (1.2)

843 (8.1)

 Sweden

366 (3.5)

361 (3.5)

295 (2.8)

307 (3.0)

1329 (12.8)

 Germany

209 (2.0)

215 (2.1)

354 (3.4)

358 (3.5)

1136 (11.0)

 Hungary

359 (3.5)

380 (3.7)

205 (2.0)

220 (2.1)

1164 (11.2)

 Spain

383 (3.7)

353 (3.4)

180 (1.7)

194 (1.9)

1110 (10.7)

Abdominal adiposity

 No

1875 (18.1)

1831 (17.7)

1754 (16.9)

1867 (18.0)

7327 (70.7)

 Yes

664 (6.4)

708 (6.8)

821 (7.9)

781 (7.5)

2974 (28.7)

 Missing

11 (0.1)

4

19 (0.2)

24 (0.2)

58 (0.6)

Elevated BP

 No

1944 (18.8)

2037 (19.7)

2109 (20.4)

2209 (21.3)

8299 (80.1)

 Yes

548 (5.3)

443 (4.3)

419 (4.0)

390 (3.8)

1800 (17.4)

 Missing

58 (0.6)

63 (0.6)

66 (0.6)

73 (0.7)

260 (2.5)

Dyslipidaemia

 No

1425 (13.8)

1406 (13.6)

1542 (14.9)

1599 (15.4)

5972 (57.7)

 Yes

385 (3.7)

408 (3.9)

315 (3.0)

292 (2.8)

1400 (13.5)

 Missing

740 (7.1)

729 (7.0)

737 (7.1)

781 (7.5)

2987 (28.8)

Insulin resistance

 No

1599 (15.4)

1520 (14.7)

1480 (14.3)

1504 (14.5)

6103 (58.9)

 Yes

442 (4.3)

496 (4.8)

332 (3.2)

342 (3.3)

1612 (15.6)

 Missing

509 (4.9)

527 (5.1)

782 (7.5)

826 (8.0)

2644 (25.5)

MetS

 No

1607 (15.5)

1605 (15.5)

1627 (15.7)

1668 (16.1)

6507 (62.8)

 Yes

159 (1.5)

165 (1.6)

127 (1.2)

117 (1.1)

568 (5.5)

 Missing

784 (7.6)

773 (7.5)

840 (8.1)

887 (8.6)

3284 (31.7)

  1. a W2 second wave of follow-up, W3 third examination wave, DM digital media, ISCED parental educational status, HDAS healthy diet adherence score (diet quality), BP blood pressure, MetS metabolic syndrome